The 2023 Johnson & Johnson U.S. Transparency Report highlights our commitment to innovation, affordability and access to medicines, while addressing policy challenges in the healthcare ecosystem. The report serves as both an analysis of pricing and a broader look at the policies affecting patient access to life-saving treatments.
Read the executive summary below, or view the full report here.
